CA
NZ
UK
AU
IND
US
…
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Teleflex Incorporated is a global medical technology company that designs, manufactures and supplies single‑use devices and instrument systems for critical care, surgical, vascular access, anesthesia and urology applications. Long-term growth may be supported by aging populations and rising procedural volumes, ongoing product innovation and selective acquisitions, while recurring consumable sales appear positioned to provide stable revenue and cash flow.
Investors should monitor regulatory and reimbursement pressures, intense competition from larger device companies, execution and integration risks from acquisitions, and vulnerabilities to supply-chain disruptions and foreign‑exchange movements.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 24.55M | 75.48M | 434.01M | 445.92M | 559.47M |
| Net income | -905.64M | 69.67M | 356.33M | 363.14M | 485.37M |
| Selling general administrative | 720.17M | 995.27M | 902.59M | 863.75M | 860.09M |
| Gross profit | 1120.75M | 1702.68M | 1646.93M | 1531.09M | 1549.60M |
| Reconciled depreciation | 177.74M | 274.60M | 237.53M | 230.59M | 237.36M |
| Ebit | 124.78M | 159.02M | 519.09M | 499.73M | 628.10M |
| Ebitda | 302.51M | 433.62M | 761.21M | 745.02M | 797.37M |
| Depreciation and amortization | 177.74M | 274.60M | 242.12M | 245.30M | 169.27M |
| Non operating income net other | - | - | - | 0.46M | -11.66M |
| Operating income | 255.80M | 151.01M | 506.31M | 499.73M | 628.10M |
| Other operating expenses | 1736.91M | 2896.31M | 2468.18M | 2277.52M | 2250.89M |
| Interest expense | 100.22M | 83.54M | 85.08M | 54.26M | 56.97M |
| Tax provision | -33.98M | 5.32M | 76.44M | 83.00M | 74.35M |
| Interest income | 6.40M | 8.01M | 9.82M | 53.35M | 55.64M |
| Net interest income | -93.82M | -75.53M | -68.52M | -53.35M | -55.64M |
| Extraordinary items | -964.17M | -0.49M | -1.24M | 0.22M | 0.26M |
| Non recurring | - | - | - | 20.30M | 21.74M |
| Income tax expense | -33.98M | 5.32M | 76.44M | 83.00M | 74.35M |
| Total revenue | 1992.71M | 3047.32M | 2974.49M | 2791.04M | 2809.56M |
| Total operating expenses | 864.95M | 1551.67M | 1140.62M | 1017.57M | 990.93M |
| Cost of revenue | 871.96M | 1344.64M | 1327.56M | 1259.95M | 1259.96M |
| Total other income expense net | -231.25M | -75.53M | -72.30M | -53.81M | -68.63M |
| Discontinued operations | - | - | - | 0.22M | 0.26M |
| Net income from continuing ops | 58.53M | 70.16M | 357.57M | 362.92M | 485.12M |
| Net income applicable to common shares | -905.64M | 69.67M | 356.33M | 363.14M | 485.37M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 6947.24M | 7097.91M | 7532.55M | 6928.06M | 6871.72M |
| Intangible assets | 1524.15M | 2268.71M | 2501.96M | 2306.16M | 2289.07M |
| Other current assets | 795.10M | 105.34M | 114.88M | 125.08M | 117.28M |
| Total liab | 3822.47M | 2819.77M | 3091.56M | 2906.09M | 3116.97M |
| Total stockholder equity | 3124.77M | 4278.14M | 4440.99M | 4021.97M | 3754.75M |
| Other current liab | 513.04M | 367.01M | 345.55M | 367.19M | 55.63M |
| Common stock | 48.20M | 48.10M | 48.05M | 47.96M | 47.93M |
| Capital stock | 48.20M | 48.10M | 48.05M | 47.96M | 47.93M |
| Retained earnings | 3149.76M | 4115.87M | 4109.74M | 3817.30M | 3517.95M |
| Other liab | - | - | - | 580.14M | 580.72M |
| Good will | 2305.05M | 2632.31M | 2914.05M | 2536.73M | 2504.20M |
| Other assets | 589.60M | 114.00M | 105.69M | 95.77M | 75.92M |
| Cash | 393.26M | 290.19M | 222.85M | 292.03M | 445.08M |
| Cash and equivalents | 378.56M | 290.19M | 222.85M | 292.03M | 445.08M |
| Total current liabilities | 762.03M | 649.36M | 606.75M | 581.49M | 680.12M |
| Current deferred revenue | - | - | 41.45M | - | 396.25M |
| Net debt | 2332.39M | 1464.84M | 1703.52M | 1539.93M | 1521.05M |
| Short term debt | 100.00M | 100.00M | 87.50M | 87.50M | 110.00M |
| Short long term debt | 100.00M | 100.00M | 87.50M | 87.50M | 110.00M |
| Short long term debt total | 2725.66M | 1755.03M | 1926.37M | 1831.96M | 1966.13M |
| Other stockholder equity | 166.28M | 430.84M | 597.61M | 560.23M | 535.82M |
| Property plant equipment | 590.10M | 611.76M | 603.43M | 578.42M | 573.41M |
| Total current assets | 1938.34M | 1471.12M | 1407.41M | 1410.98M | 1429.12M |
| Net tangible assets | - | - | - | -820.93M | -1038.52M |
| Short term investments | - | 15.97M | 16.88M | - | - |
| Net receivables | 345.58M | 459.50M | 443.47M | 408.83M | 383.57M |
| Long term debt | 2541.45M | 1555.87M | 1727.57M | 1624.02M | 1740.10M |
| Inventory | 404.39M | 600.13M | 626.22M | 578.51M | 477.64M |
| Accounts payable | 130.20M | 141.03M | 132.25M | 126.81M | 118.24M |
| Accumulated other comprehensive income | -239.47M | -316.67M | -314.40M | -403.52M | -346.96M |
| Common stock total equity | - | - | - | 47.96M | 47.93M |
| Retained earnings total equity | - | - | - | 3817.30M | 3517.95M |
| Treasury stock | - | - | - | -154.89M | -157.27M |
| Non currrent assets other | 565.82M | 102.62M | 98.94M | 89.37M | 69.10M |
| Non current assets total | 5008.90M | 5626.79M | 6125.14M | 5517.08M | 5442.60M |
| Capital lease obligations | 84.21M | 99.15M | 111.30M | 120.44M | 116.03M |
| Long term debt total | 2541.45M | 1555.87M | 1727.57M | 1624.02M | 1740.10M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -5.00M | -99.36M | -258.43M | -257.94M | -18.42M |
| Change to liabilities | - | - | - | -104.24M | 94.02M |
| Total cashflows from investing activities | -849.19M | -99.36M | -621.23M | -257.94M | 156.74M |
| Net borrowings | 987.00M | -161.50M | 101.25M | -145.45M | -634.50M |
| Total cash from financing activities | 611.54M | -421.93M | 38.54M | -217.51M | -715.82M |
| Change to operating activities | - | - | - | 13.42M | -28.41M |
| Net income | 58.53M | 69.67M | 356.33M | 363.14M | 485.37M |
| Change in cash | 73.68M | 104.80M | -69.19M | -153.05M | 69.20M |
| Begin period cash flow | 304.89M | 222.85M | 292.03M | 445.08M | 375.88M |
| End period cash flow | 378.56M | 327.65M | 222.85M | 292.03M | 445.08M |
| Total cash from operating activities | 340.68M | 635.74M | 510.64M | 342.14M | 651.42M |
| Issuance of capital stock | - | - | 0.00M | 0.00M | 11.10M |
| Depreciation | 177.74M | 274.60M | 242.12M | 230.59M | 237.36M |
| Other cashflows from investing activities | 76.19M | 27.20M | 63.13M | -178.75M | 228.35M |
| Dividends paid | 60.27M | 63.54M | 63.90M | -63.79M | -63.65M |
| Change to inventory | 84.04M | 1.72M | -41.07M | -110.69M | -11.14M |
| Change to account receivables | -85.53M | -27.95M | -15.76M | -38.46M | -0.60M |
| Sale purchase of stock | -300.00M | -200.00M | 5.19M | -4.31M | 412.45M |
| Other cashflows from financing activities | -10.23M | 3.12M | 1.19M | 730.78M | -41.22M |
| Change to netincome | - | - | - | -6.16M | -203.16M |
| Capital expenditures | 95.24M | 126.43M | 91.44M | 79.19M | 71.62M |
| Change receivables | - | - | - | -38.46M | -0.60M |
| Cash flows other operating | - | - | - | 3.90M | -115.80M |
| Cash and cash equivalents changes | - | - | - | -134.11M | 93.05M |
| Change in working capital | -81.09M | -1.82M | -111.77M | -239.96M | 127.34M |
| Stock based compensation | 25.70M | 31.35M | 31.46M | 27.22M | 22.94M |
| Other non cash items | 286.46M | 261.94M | 5.54M | -25.84M | -111.36M |
| Free cash flow | 245.44M | 509.31M | 419.20M | 262.95M | 579.80M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| TFX Teleflex Incorporated |
-0.02 0.01% |
138.98 | - | 11.49 | 2.42 | 1.90 | 3.59 | 31.63 |
| ISRG Intuitive Surgical Inc |
-1.70 0.38% |
444.18 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
-3.50 1.72% |
200.50 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
-2.13 2.10% |
99.11 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
0.13 0.07% |
195.16 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
550 East Swedesford Road, Wayne, PA, United States, 19087-1603
610-225-6800
15500
| Name | Title | Year Born |
|---|---|---|
| Mr. Liam J. Kelly | Chairman, Pres & CEO | 1967 |
| Mr. Thomas E. Powell | Exec. VP & CFO | 1962 |
| Mr. Cameron P. Hicks | Corp. VP & Chief HR Officer | 1965 |
| Mr. Jay White | Corp. VP & Pres of Global Commercial | 1974 |
| Mr. James P. Winters | Corp. VP, Manufacturing and Supply Chain | NA |
| Mr. John R. Deren | Corp. VP & Chief Accounting Officer | NA |
| Mr. John Hsu C.F.A. | VP of Investor Relations | NA |
| Mr. Daniel V. Logue | Corp. VP, Gen. Counsel & Sec. | 1974 |
| Mr. Howard Cyr | Corp. VP & Chief Compliance Officer | NA |
| Mr. Matt Tomkin | VP of Corp. Devel. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.02%
Communication Services
-0.63%
Consumer Cyclical
-0.11%
Consumer Defensive
-0.45%
Energy
+0.39%
Financial Services
-0.10%
Financials
-0.81%
Healthcare
+1.03%
Industrials
+0.32%
Real Estate
-0.31%
Technology
+0.59%
Utilities
-0.18%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...